Seres Therapeutics Inc (NAS:MCRB)
$ 0.915 0.038 (4.33%) Market Cap: 156.22 Mil Enterprise Value: 176.53 Mil PE Ratio: 0 PB Ratio: 6.54 GF Score: 47/100

Q2 2021 Seres Therapeutics Inc Earnings Call Transcript

Aug 03, 2021 / 12:30PM GMT
Release Date Price: $6.96 (-1.00%)
Operator

Good morning, ladies and gentlemen, and welcome to the Seres Therapeutics Q2 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Dr. Carlo Tanzi of Investor Relations.

Carlo Tanzi
Seres Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, and good morning. Our press release with the company's second quarter 2021 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and News section of the company's website. I'd like to remind you that we'll be making forward-looking statements relating to the timing, enrollment and results of our clinical studies, the anticipated safety profile of our products, regulatory approval, the success of our agreement with Nestlé, the sufficiency and availability of cash to fund operations and the promise and potential impact of any of our microbiome therapeutics. Actual results may differ materially.

Additionally,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot